Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers

Overview of attention for article published in American Journal of Hematology, August 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 35,998 followers.

RT @LysaLymphoma: Efficacy of salvage therapies for unsatisfactory response to anti-PD-1 therapy in 30 R/R HL patients in the LYSA network…

RT @LysaLymphoma: Efficacy of salvage therapies for unsatisfactory response to anti-PD-1 therapy in 30 R/R HL patients in the LYSA network…

RT @LysaLymphoma: Efficacy of salvage therapies for unsatisfactory response to anti-PD-1 therapy in 30 R/R HL patients in the LYSA network…

RT @LysaLymphoma: Efficacy of salvage therapies for unsatisfactory response to anti-PD-1 therapy in 30 R/R HL patients in the LYSA network…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.